P15 KE-P15 · inpatient visit

One row per condition family: what the record supports under the published definition, what the note states, the visit's diagnosis entries, and an assessment. Codes are coded from the signed documentation; the software never assigns one.

Library check LRUN-00015 · library_default_set@1.0 · library-engine 1.0 · replay 7ec5fd4e26dc2335… · Data (JSON)

Draft query: Hyperkalaemia

Blocked by the query linter

A non-leading clarification request: clinical indicators with their sources, an open question, several options plus "other" and "unable to determine". No code and no payment word; the same indicators cannot be queried twice.

DOCUMENTATION QUERY (draft) for KE-P15 · potassium
Title: Clarification request: potassium results
Encounter: KE-P15   Patient: P15   To: author of the draft note
From: (no named sender: sign in to send)
Date: 2026-11-13   Rule versions: ukka2026_hyperkalaemia@1.0, library_default_set@1.0   Check run: LRUN-00015

Clinical indicators from the health record:
- Potassium 5.8 mmol/L (2026-11-12 15:00) [measurement LM-P15-02]

Question:
Based on your independent clinical judgement, how would you describe the clinical significance of the potassium results listed above?

Response options (select one or write your own):
( ) Hyperkalemia
( ) Not clinically significant for this encounter
( ) Other (please specify): ____________
( ) Unable to determine

Please respond based on your independent clinical judgement. Any response, including "unable to determine", is acceptable. This query and your response are kept as part of the health record.

error · no_sender: A query needs a named human sender (sign in).

Condition families for this encounter (2)
Condition family	What the record supports	What the note states	Visit diagnosis entries	Assessment
Hyperkalaemia measured	`ukka2026_hyperkalaemia@1.0` Draft · pending review Mild hyperkalaemia (5.5–5.9 mmol/L) potassium serum 5.8 mmol/L 2026-11-12 15:00 · LM-P15-02 Window: 14 days before the check. Citation Hyperkalaemia and its severity (UK Kidney Association, July 2026 update) ukka2026_hyperkalaemia@1.0 It is further classified by severity into mild (5.5-5.9 mmol/l), moderate (6.0-6.4 mmol/l) or severe (≥ 6.5 mmol/l). UK Kidney Association, Clinical Practice Guidelines: Treatment of Acute Hyperkalaemia in Adults (2026) · Introduction, document page 9 (PDF page 10) · source Contested: The guideline itself says 'There is no universally accepted definition of hyperkalaemia'; it adopts the ERC threshold of 5.5 mmol/L. CTCAE grades differ (see ctcae6_hyperkalaemia). Not encoded: Pseudohyperkalaemia (guideline 15.3: haemolysis, delayed analysis, sampling technique) is not detected; a haemolysed sample is graded like any other unless the sender withholds it. Acute versus chronic (persistent) hyperkalaemia and the guideline's repeat-testing intervals (guidelines 1.2.1-1.2.3) are not encoded. ECG changes and clinical context are not assessed.	Not stated	None entered	The record supports it; neither stated in the note nor entered Draft a query
Code-family reference: Hyperkalaemia Coders only reference for coders — the clinician's documented statement governs; the software does not assign codes `E87` Other disorders of fluid, electrolyte and acid-base balance: distinguishes E87.5 hyperkalemia (one code; no severity axis) (14 codes in the category). `E87.0` Hyperosmolality and hypernatremia `E87.1` Hypo-osmolality and hyponatremia `E87.20` Acidosis, unspecified `E87.21` Acute metabolic acidosis `E87.22` Chronic metabolic acidosis `E87.29` Other acidosis `E87.3` Alkalosis `E87.4` Mixed disorder of acid-base balance `E87.5` Hyperkalemia `E87.6` Hypokalemia `E87.70` Fluid overload, unspecified `E87.71` Transfusion associated circulatory overload `E87.79` Other fluid overload `E87.8` Other disorders of electrolyte and fluid balance, not elsewhere classified Source: official ICD-10-CM FY2027 code descriptions (extract in library/data/code_reference_fy2027.json).
Septic shock (lactate component) judgement tier	`sepsis3_septic_shock_lactate@1.0` Draft · pending review Lactate >2 mmol/L (18 mg/dL): the Sepsis-3 septic-shock lactate criterion is met lactate serum 2.6 mmol/L 2026-11-11 15:10 · LM-P15-03 Window: 7 days before the check. Citation Serum lactate above the Sepsis-3 septic-shock threshold (numeric component only) sepsis3_septic_shock_lactate@1.0 persisting hypotension requiring vasopressors to maintain MAP ≥65 mm Hg and having a serum lactate level >2 mmol/L (18mg/dL) despite adequate volume resuscitation Society of Critical Care Medicine and European Society of Intensive Care Medicine task force (JAMA 2016;315:801-810), The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) (2016) · Box 3 'New Terms and Definitions' · source Not encoded: Septic shock also requires sepsis (suspected or documented infection with an acute increase in SOFA ≥2), persisting hypotension requiring vasopressors to maintain MAP ≥65 mm Hg, and adequate volume resuscitation; none of these is assessed. This entry never says septic shock is present. Timing of the lactate relative to resuscitation is not checked; the most recent value is used.	Not stated	None entered	Cannot be assessed judgement tier: the record shows these values; the condition needs clinical judgement
Code-family reference: Septic shock (lactate component) Coders only reference for coders — the clinician's documented statement governs; the software does not assign codes Source: official ICD-10-CM FY2027 code descriptions (extract in library/data/code_reference_fy2027.json).